GSK plc has agreed to acquire IDRx, a Boston-based, clinical-stage biopharmaceutical company dedicated to developing ...

ILC Dover, an Ingersoll Rand Business, has launched Sentinel XT Horizon, a new addition to the Sentinel XT line of Powered ...

Rappta Therapeutics, a private biotech focused on developing anti-cancer drugs activating protein phosphatase 2A (PP2A), has ...

Iconovo AB, a developer of inhalable drugs based on proprietary inhalers and dry powder formulations, and Lonza, a healthcare ...

Telix Pharmaceuticals Limited has entered into an asset purchase agreement with antibody engineering company ImaginAb Inc. to ...

Johnson & Johnson has agreed to acquire all outstanding shares of Intra-Cellular Therapies Inc., a biopharmaceutical company ...

Alcami Corp., a contract development and manufacturing organization, announced the resignation of Bill Humphries. Alcami’s ...

AbbVie and Simcere Zaiming, a subsidiary of Simcere Pharmaceutical Group Ltd., entered an option to license agreement to ...

Synthego granted global license to manufacture and distribute AZ's CRISPR gene editing enzyme, eSpOT-ON.

Expands development services for growth in ophthalmic clinical research.

Veeda Group has unveiled a new logo and brand identity— Veeda Lifesciences —reflecting the brand’s evolution from a ...

Innovent Biologics Inc., a biopharmaceutical company that develops, manufactures and commercializes medicines, has entered a ...